Phase 2 trial of the monoclonal antibody Axatilimab shows modest doses attenuate symptoms.
Cancer
Research and innovation from the oncology experts at Vanderbilt-Ingram Cancer Center
Teamwork and Trials Halt Brain Cancer Metastasis
VUMC expertise and clinical trials attract patients from around the region.
Read More
Latest in Cancer
Antibody Aimed at Monocytes in Graft-Versus-Host Disease
Teams Map Early Progress of Colorectal Cancer
Targeting the 90 Percent: Treatment-Resistant Colorectal Cancers
Vanderbilt is creating a roadmap of colorectal cancer progression as part of an NCI-funded Cancer Moonshot initiative.
Renowned researchers tee up trial of immunotherapy for microsatellite-stable tumors.
Partners in Care
Medical expertise infused with integrated technology allows Vanderbilt Health specialists to build partnerships and elevate care in complex and specialized cases. Browse our referral directory or log into our online portal for referring providers.
Make a Referral
Focal therapy for prostate cancer could reduce the risk of major treatment-related repercussions.
Researchers design GeneMAP en route to defining biological function of “orphan” protein.
A new style of advanced-care planning packet helped increase the number of patients with advance directives in the EMR.
Examination of two bronchoscopy systems points to optimal diagnosis method for patients.
VUMC oncologists and pathologists update best practices in surgical margins involving bone and soft tissue sarcomas.
Loss of the von Hippel Lindau gene uniquely affects kidney cancer by upregulating a tumor-friendly chemokine.